Blood purification for critical illness: Cytokines adsorption therapy

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 1, 2006, Pages 25-31

  Tsuchida, Kenji ^a   Yoshimura, Rikio ^a   Nakatani, Tatsuya ^a   Takemoto, Yoshiaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adsorption; Blood purification; Cytokines; Lixelle; SIRS

Indexed keywords

BETA 2 MICROGLOBULIN; CYTOKINE; GLYCOPROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; BLOOD; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DISEASE COURSE; GRAM POSITIVE BACTERIUM; HEMOPERFUSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; REVIEW; SEPSIS; SHOCK; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADSORPTION; ANIMALS; CRITICAL ILLNESS; CYTOKINES; HEMOPERFUSION; HUMANS; INTERLEUKIN-6; MALE; RATS; RATS, WISTAR; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644990482     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00342.x     Document Type: Review

References (26)

1. Angus DC Wax RS Epidemiology of sepsis: an update Crit Care Med 2001 29 S109 S116
2. Angus DC Linde-Zwirble WT Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [comment] Crit Care Med 2001 29 1303 10
3. Bone RC Balk RA Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 1992 101 1644 55
4. Ohlsson K Bjork P Bergenfeldt M et al. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock Nature 1990 348 550 2
5. Calandra T Echtenacher B Roy DL et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor Nature Med 2000 6 164 70
6. Haslett C Granulocyte apoptosis and its role in the resolution and control of lung inflammation Am J Respir Crit Care Med 1999 160 S5 S11
7. Niwa M Milner KC Ribi E Rudbach JA Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali J Bacteriol 1969 97 1069 77
8. Tsuchida K Takemoto Y Yamagami S et al. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods Nephron 1997 75 438 43
9. Martin TR Mathison JC Tobias PS et al. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs J Clin Invest 1992 90 2209 2019
10. Natanson C Hoffman WD Koev LA et al. Plasma exchange does not improve survival in a canine model of human septic shock Transfusion 1993 33 243 8
11. Hanasawa K Aoki H Yoshioka T Matsuda K Tani T Kodama M Novel mechanical assistance in the treatment of endotoxic and septicemic shock ASAIO Trans 1989 35 341 3
12. Nakazawa R Azuma N Suzuki M et al. A new treatment for dialysis related amyloidosis with β2-microglobulin adsorbent column Int J Artif Organs 1993 16 823 9
13. Furuyoshi S Nakatani M Taman J Kutsuki H Takata S Tani N New adsorption column (Lixelle) to eliminate β2-microglobulin for direct hemoperfusion Ther Apher 1998 2 13 17
14. Tsuchida K Takemoto Y Nakamura T et al. Lixelle adsorbent to remove inflammatory cytokines Artif Organs 1998 22 1064 7
15. Tsuchida K Takemoto Y Nakatani T Nakamura T Sugimura K Yamamoto K Adsorption of microorganism components by lixelle beads Artif Organs 2000 24 577 80
16. Nakatani T Tsuchida K Fu O Sugimura K Takemoto Y Effects of direct hemoperfusion with a β2-microglobulin adsorption column on hypercytokinemia in rates Blood Purif 2003 21 145 51
17. Tsuchida K Takemoto Y Sugimura K Yoshimura R Nakatani T Direct hemoperfusion by using Lixelle column for the treatment of systemic inflammatory response syndrome Int J Mol Med 2002 10 485 8
18. Vincent JL Abraham E Annane D Bernard G Rivers E Van den Berghe G Reducing mortality in sepsis: new directions Crit Care 2002 6 S1 S18
19. Oda S Hirasawa H Shiga H Nakanishi K Matsuda K Nakamura M Continuous hemofiltration/hemodiafiltration in critical care Ther Apher 2002 6 193 8
20. Kikuchi H Maruyama H Omori S Kazama JJ Gejyo F The sequential organ failure assessment score as a useful predictor for estimating the prognosis of systemic inflammatory response syndrome patients being treated with extracorporeal blood purification Ther Apher Dial 2003 7 456 60
21. Homma N Gejyo F Hasegawa S et al. Effects of a new adsorbent column for removing beta-2-microglobulin from circulating blood of dialysis patients Contrib Nephrol 1995 112 164 71
22. Inoue H Saito I Nakazawa R Azuma N Suzuki M Miyasaka N Eluate from beta 2MG adsorbent beads enhances the expression of IL-1 beta from human monocyte Nephrol Dial Transplant 1995 10 2161 2
23. Berlot G Gullo A Fasiolo S Serra L Silvestri L Worz M Hemodynamic effects of plasma exchange in septic patients: preliminary report Blood Purif 1997 15 45 53
24. Cornwell TL Arnold E Boerth NJ Lincoln TM Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP Am J Physiol 1994 267 1405 13
25. Windsor AC Kanwar S Li AG et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis Gut 1998 42 431 5
26. Jaber BL Barrett TW Cendoroglo NetoM et al. Endotoxin removal by polymyxin-B immobilized polystyrene-derivative fibers during in vitro hemoperfusion of 10% human plasma ASAIO J 1998 44 54 61